Innoviva (INVA) FCF Payout Ratio (QoQ) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 199.72% |
| Jun 30, 2022 | 82.13% |
| Sep 30, 2021 | -26.70% |
| Jun 30, 2021 | -5.85% |
| Mar 31, 2021 | 759.15% |
| Jun 30, 2020 | -29.23% |
| Mar 31, 2020 | 36.55% |
| Jun 30, 2019 | -49.12% |
| Mar 31, 2019 | -99.79% |
| Dec 31, 2018 | 50.05% |
| Sep 30, 2018 | 98.77% |
| Jun 30, 2018 | 2,086.46% |
| Mar 31, 2018 | -87.03% |
| Dec 31, 2017 | 338.64% |
| Sep 30, 2017 | -239.25% |
| Jun 30, 2017 | -26.79% |
| Mar 31, 2017 | -21.81% |
| Dec 31, 2016 | 18.40% |
| Sep 30, 2016 | -73.82% |
| Jun 30, 2016 | -89.96% |
| Mar 31, 2016 | 266.78% |
| Dec 31, 2015 | -99.75% |
| Sep 30, 2015 | -18.57% |
| Jun 30, 2015 | 175.79% |
| Mar 31, 2015 | -193.89% |
| Dec 31, 2014 | -349.15% |